MICROWAVE-ASSISTED, ONE-POT SYNTHESISOFNOVELHEXA HYDRO IMIDAZO [1,2-a] PYRIDINE: WITHDIVERSECATALYST SCREENING AND INSILICO-STUDIES
RASAYAN Journal of Chemistry · 2026 · 19 (02) · 877-883
DOI: 10.31788/rjc.2026.1929652 ↗Kurz gefasst
Fachartikel in der Zeitschrift RASAYAN Journal of Chemistry, 2026. Verfasst von M Malleli und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
A microwave-assisted, one-pot, three-component synthesis of Imidazo [1,2-a] pyridine using four different catalystswas reported. The authors primarily focused on methodological development rather than synthesis of multiplederivatives, comparing reaction times and yields with those obtained under conventional conditions. Most importantly, in silico studies were conducted on the newly synthesised compound using the crystal structure of theenzyme 1A3 (PDB ID: 6TE5. Imidazo [1,2-a] pyridine derivatives are known inhibitors of aldehyde dehydrogenase1A3 (ALDH1A3), an enzyme whose overexpression is associated with various cancers, including breast, lung, brainand colon cancers.
Zitieren
APA
Malleli, M., Syeda, A. B., Eppakayala, L., & Kethireddy, S. (2026). MICROWAVE-ASSISTED, ONE-POT SYNTHESISOFNOVELHEXA HYDRO IMIDAZO [1,2-a] PYRIDINE: WITHDIVERSECATALYST SCREENING AND INSILICO-STUDIES. RASAYAN Journal of Chemistry, 19(02), 877-883. https://doi.org/10.31788/rjc.2026.1929652
Vancouver
Malleli M, Syeda AB, Eppakayala L, Kethireddy S. MICROWAVE-ASSISTED, ONE-POT SYNTHESISOFNOVELHEXA HYDRO IMIDAZO [1,2-a] PYRIDINE: WITHDIVERSECATALYST SCREENING AND INSILICO-STUDIES. RASAYAN Journal of Chemistry. 2026;19(02):877-883. doi:10.31788/rjc.2026.1929652
BibTeX
@article{Malleli2026,
author = {Malleli, M and Syeda, A. B and Eppakayala, L and Kethireddy, S},
title = {MICROWAVE-ASSISTED, ONE-POT SYNTHESISOFNOVELHEXA HYDRO IMIDAZO [1,2-a] PYRIDINE: WITHDIVERSECATALYST SCREENING AND INSILICO-STUDIES},
journal = {RASAYAN Journal of Chemistry},
year = {2026},
volume = {19},
number = {02},
pages = {877--883},
doi = {10.31788/rjc.2026.1929652}
}
EUVIMED